Your browser doesn't support javascript.
loading
Ezrin promotes hepatocellular carcinoma progression by modulating glycolytic reprogramming.
Wang, Xinyue; Li, Nan; Han, Anna; Wang, Yixuan; Lin, Zhenhua; Yang, Yang.
Afiliación
  • Wang X; Department of Pathology and Cancer Research Center, Yanbian University Medical College, Yanji, China.
  • Li N; Key Laboratory of the Science and Technology Department of Jilin Province, Yanji, China.
  • Han A; Institute of Virology, Wenzhou University, Wenzhou, China.
  • Wang Y; Department of Pathology and Cancer Research Center, Yanbian University Medical College, Yanji, China.
  • Lin Z; Key Laboratory of the Science and Technology Department of Jilin Province, Yanji, China.
  • Yang Y; Department of Pathology and Cancer Research Center, Yanbian University Medical College, Yanji, China.
Cancer Sci ; 111(11): 4061-4074, 2020 Nov.
Article en En | MEDLINE | ID: mdl-32639665

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Proteínas del Citoesqueleto / Metabolismo Energético / Reprogramación Celular / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Proteínas del Citoesqueleto / Metabolismo Energético / Reprogramación Celular / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Año: 2020 Tipo del documento: Article País de afiliación: China